radioresistance

(redirected from radioresistant)
Also found in: Dictionary, Medical, Wikipedia.

radioresistance

[¦rād·ē·ō·ri′zis·təns]
(biology)
The resistance of organisms or tissues to the harmful effects of various radiations.
Mentioned in ?
References in periodicals archive ?
This was particularly important in female patients who had nine times higher risk in OS than those with radioresistant phenotype (Table 6).
Bourlon et al., "Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?" Practical Radiation Oncology, vol.
This observation is completely at odds with all previous studies, which link increased EGFR expression with drug or radioresistant phenotypes.
The topic of whether mesenchymal stem cells (MSCs) are radiosensitive or radioresistant is still controversial.
SMM is considered a radioresistant tumour; however, adjuvant radiotherapy may show some benefit by increasing cancer-specific survival (21).
Primary RCC has typically been viewed as a radioresistant tumor, with radiation therapy not considered first line.
Lidstrom, "Global whole-cell FTICR mass spectrometric proteomics analysis of the heat shock response in the radioresistant bacterium Deinococcus radiodurans," Journal of Proteome Research, vol.
Plitz et al., "Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells," The Journal of Experimental Medicine, vol.
MiR-205 has been published to be downregulated in radioresistant breast cancer cells and targets ZEB1 and Ubc13 [66].
Traditionally, chondrosarcomas have been thought to be relatively radioresistant, due, in part, to their low-grade nature [16, 24].
Radioresistant breast cancer cells showed CSC-like properties and elevation of [beta]-catenin.
Jeon et al., "ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer," Oncotarget, vol.